NASDAQ:ALGN - Align Technology Stock Price, News, & Analysis

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Align Technology, Inc. (NASDAQ:ALGN) announced its quarterly earnings results on Wednesday, July, 25th. The medical equipment provider reported $1.30 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.09 by $0.21. The medical equipment provider earned $490.26 million during the quarter, compared to analyst estimates of $472.10 million. Align Technology had a return on equity of 32.61% and a net margin of 17.00%. The firm's revenue was up 37.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.85 EPS. View Align Technology's Earnings History.

Align Technology is scheduled to release their next quarterly earnings announcement on Thursday, October, 25th 2018. View Earnings Estimates for Align Technology.

Align Technology issued an update on its third quarter earnings guidance on Wednesday, July, 25th. The company provided EPS guidance of $1.13-1.18 for the period, compared to the Thomson Reuters consensus estimate of $1.19. The company issued revenue guidance of $493-503 million, compared to the consensus revenue estimate of $498.98 million.

15 Wall Street analysts have issued twelve-month price targets for Align Technology's stock. Their forecasts range from $210.00 to $430.00. On average, they anticipate Align Technology's stock price to reach $356.40 in the next year. This suggests that the stock has a possible downside of 0.3%. View Analyst Price Targets for Align Technology.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 3 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Align Technology.

Some companies that are related to Align Technology include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), WILLIAM DEMANT/ADR (WILYY), Steris (STE), Inogen (INGN), MSA Safety (MSA), Wright Medical Group (WMGI), Avanos Medical (AVNS), Halyard Health (HYH), CONSORT Med PLC/S (CSRMY), Sientra (SIEN) and Invacare (IVC).

Press coverage about ALGN stock has been trending somewhat positive this week, Accern reports. Accern scores the sentiment of news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Align Technology earned a coverage optimism score of 0.12 on Accern's scale. They also assigned media headlines about the medical equipment provider an impact score of 45.89 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days. View Recent Headlines for Align Technology.

Align Technology's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.41%), Renaissance Technologies LLC (3.60%), Polen Capital Management LLC (2.95%), FMR LLC (2.12%), Bank of New York Mellon Corp (1.41%) and Disciplined Growth Investors Inc. MN (1.16%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, David L White, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Sreelakshmi Kolli, Stuart A Hockridge, Thomas M Prescott and Warren S Thaler. View Institutional Ownership Trends for Align Technology.

ALGN stock was sold by a variety of institutional investors in the last quarter, including Polen Capital Management LLC, Janus Henderson Group PLC, CIBC Private Wealth Group LLC, Bank of New York Mellon Corp, Eagle Asset Management Inc., Jennison Associates LLC, Russell Investments Group Ltd. and Wells Fargo & Company MN. Company insiders that have sold Align Technology company stock in the last year include C Raymond Larkin Jr, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Stuart A Hockridge, Thomas M Prescott and Warren S Thaler. View Insider Buying and Selling for Align Technology.

ALGN stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Winslow Capital Management LLC, BlackRock Inc., First Republic Investment Management Inc., Sei Investments Co., Fred Alger Management Inc., Scout Investments Inc. and Artisan Partners Limited Partnership. View Insider Buying and Selling for Align Technology.

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALGN stock can currently be purchased for approximately $357.30.

Align Technology has a market capitalization of $29.28 billion and generates $1.47 billion in revenue each year. The medical equipment provider earns $231.41 million in net income (profit) each year or $3.89 on an earnings per share basis. Align Technology employs 8,715 workers across the globe.

Align Technology's mailing address is 2560 ORCHARD PARKWAY, SAN JOSE CA, 95131. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]